The public health imperative for a neonatal herpes simplex virus infection surveillance system

被引:19
作者
Donoval, BA
Passaro, DJ
Klausner, JD
机构
[1] Univ Illinois, Sch Publ Hlth, Div Epidemiol, Chicago, IL 60612 USA
[2] San Francisco Dept Publ Hlth, STD Prevent & Control Serv, San Francisco, CA USA
关键词
D O I
10.1097/01.olq.0000187203.27918.45
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
About 1 in 5 sexually active adults in the United States has serologic evidence of genital herpes caused by herpes simplex virus type-2. Neonatal herpes simplex virus infection is a serious consequence of genital herpes infection. Herpes infection in neonates causes significant morbidity and neurologic damage and generally has a case-fatality ratio untreated of 60%. It is estimated that 440 to 1320 cases of neonatal herpes infections occur in the United States per year (11-33 cases occur per 100,000 live births). Given the challenges in surveillance for genital herpes due to the large number of asymptomatic infections and infrequent laboratory-based diagnosis, we recommend that to begin an effective national control program for herpes infections, a mandatory national surveillance system for neonatal herpes be implemented. Such a system would help assure appropriate therapy, help monitor trends and understand the burden of disease, identify risk determinants, and evaluate prevention efforts.
引用
收藏
页码:170 / 174
页数:5
相关论文
共 35 条
[1]  
BAUER H, 2003, NCSD HSV HPV PROGRAM
[2]   Effect of serologic status and Cesarean delivery on transmission rates of herpes simplex virus from-mother to infant [J].
Brown, ZA ;
Wald, A ;
Morrow, RA ;
Selke, S ;
Zeh, J ;
Corey, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (02) :203-209
[3]   NEONATAL HERPES-SIMPLEX VIRUS-INFECTION IN RELATION TO ASYMPTOMATIC MATERNAL INFECTION AT THE TIME OF LABOR [J].
BROWN, ZA ;
BENEDETTI, J ;
ASHLEY, R ;
BURCHETT, S ;
SELKE, S ;
BERRY, S ;
VONTVER, LA ;
COREY, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (18) :1247-1252
[4]   The estimated direct medical cost of sexually transmitted diseases among American youth, 2000 [J].
Chesson, HW ;
Blandford, JM ;
Gift, TL ;
Tao, GY ;
Irwin, KL .
PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2004, 36 (01) :11-19
[5]   Once-daily valacyclovir to reduce the risk of transmission of genital herpes [J].
Corey, L ;
Wald, A ;
Patel, R ;
Sacks, SL ;
Tyring, SK ;
Warren, T ;
Douglas, JM ;
Paavonen, J ;
Morrow, RA ;
Beutner, KR ;
Stratchounsky, LS ;
Mertz, G ;
Keene, ON ;
Watson, HA ;
Tait, D ;
Vargas-Cortes, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (01) :11-20
[6]   Genital herpes and public health - Addressing a global problem [J].
Corey, L ;
Handsfield, HH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (06) :791-794
[7]  
Crosby Richard A, 2003, J Pediatr Adolesc Gynecol, V16, P39, DOI 10.1016/S1083-3188(02)00204-8
[8]  
ELLIOTT E, 2004, COMMUN DIS INTELL, V28, P4
[9]   Herpes simplex virus type 2 in the United States, 1976 TO 1994 [J].
Fleming, DT ;
McQuillan, GM ;
Johnson, RE ;
Nahmias, AJ ;
Aral, SO ;
Lee, FK ;
StLouis, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (16) :1105-1111
[10]   The potential epidemiological impact of a genital herpes vaccine for women [J].
Garnett, GP ;
Dubin, G ;
Slaoui, M ;
Darcis, T .
SEXUALLY TRANSMITTED INFECTIONS, 2004, 80 (01) :24-29